Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: February 17, 2005
This report is a summary of the workshop, "Economic Models of Colorectal Cancer Screening in Average-Risk Adults" that was held by the Institute of Medicine's National Cancer Policy Board on January 26-27, 2004, to explore the reasons for differences among leading cost-effectiveness analysis models of CRC screening.
Released: November 16, 2004
There has been increased concern about the prospect of an influenza pandemic, which many experts believe to be inevitable. Yet the general public does not appear to share this perception, especially in the shadow of equally scary but less likely risks of a bioterrorist attack. Moreover, recent problems with the availability and strain-specificity of vaccine for annual flu epidemics in some countries and the rise of pandemic strains of avian flu in disparate geographic regions have alarmed experts about the world's ability to prevent or contain a human pandemic. The workshop summary, The Threat of Pandemic Influenza: Are We Ready? A Workshop Summary, addresses this urgent concern.
Released: September 29, 2004
In response to a request from Congress for a prevention-oriented action plan to tackle the alarming rise in childhood obesity, the IOM Committee on Prevention of Obesity in Children and Youth has developed a comprehensive national strategy that recommends specific actions for families, schools, industry, communities, and government. The committee's findings and recommendations are described in the report Preventing Childhood Obesity: Health in the Balance.
Released: September 14, 2004
On January 6 and 7, 2004, the Institute of Medicine (IOM) hosted the 1st Annual Crossing the Quality Chasm Summit, convening a diverse group of national and community health care leaders to pool their knowledge and resources with regard to strategies for improving patient care for five common chronic illnesses: asthma, depression, diabetes, heart failure, and pain control in advanced cancer.
Released: July 28, 2004
Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects assists policymakers in evaluating the appropriate scientific methods for detecting unintended changes in food and assessing the potential for adverse health effects from genetically modified products. In this report, the committee recommended that greater scrutiny should be given to foods containing new compounds or unusual amounts of naturally occurring substances, regardless of the method used to create them.
Released: July 07, 2004
An estimated forty million people carry the human immunodeficiency virus (HIV), and five million more become newly infected annually. In recent years, many HIV-infected patients in wealthy nations have eAffiliateMarketIngtoolsed significantly longer, good-quality lives as a result of antiretroviral therapy (ART). However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regions--especially sub-Saharan Africa--is begetting economic and social collapse. To inform the multiple efforts underway to deploy antiretroviral drugs in resource-poor settings, the Institute of Medicine committee was asked to conduct an independent review and assessment of rapid scale-up ART programs.
Released: July 06, 2004
In this report, the committee discusses some of the challenges and opportunities likely to arise as public health preparedness is being integrated into the broader field of emergency and disaster preparedne
Released: June 15, 2004
This report summarizes a two-day workshop held by the Institute of Medicine's Forum on Microbial Threats on October 21–22, 2002, to address the infectious etiology of chronic diseases. Invited experts presented research findings on a range of recognized and potential chronic sequelae of infections, as well as on diverse pathogenic mechanisms leading from exposure to chronic disease outcomes
Released: April 27, 2004
The Institute of Medicine's Forum on Microbial Threats will host the public workshop Pandemic Influenza: Assessing Capabilities for Prevention and Response on June 16 and 17, 2004, in , D.C. Through invited presentations and discussion, this workshop will aim to inform the Forum, the public, and policymakers of the likelihood of an influenza pandemic and to explore the issues that must be resolved now to prepare and protect the global community.
Released: April 01, 2004
Although vitamin and supplement manufacturers are restricted from claiming that using their products leads to therapeutic benefits, surveys show that many people take supplements for purposes such as treating colds or alleviating depression. According to other survey data, the majority of consumers believe these products to be either reasonably or completely safe. To bolster the FDA's ability to evaluate the safety of dietary supplements, the Institute of Medicine report Dietary Supplements: A Framework for Evaluating Safety outlines a science-based process for assessing supplement ingredients, even when data about a substance's safety in humans is scarce.